| Literature DB >> 36002794 |
Hao Peng1,2, Wei Liu2, Kai-Tao Jian2, Yu Xia2, Jian-Shi Liu2, Li-Zhong Sun3, Yun-Qing Mei4.
Abstract
BACKGROUND: This study investigated the impact of coronary angiography on outcomes of emergency operation in acute type A aortic dissection (ATAAD) patients who were initially misdiagnosed as an acute coronary syndrome.Entities:
Keywords: Antiplatelet therapy; Aortic dissection; Coronary angiography; Emergency operation; Misdiagnosis
Mesh:
Year: 2022 PMID: 36002794 PMCID: PMC9400216 DOI: 10.1186/s12872-022-02821-4
Source DB: PubMed Journal: BMC Cardiovasc Disord ISSN: 1471-2261 Impact factor: 2.174
Fig. 1Perigraft to right atrial shunt. The residual autologous aortic wall was wrapped around the prosthetic graft. A pericardial patch was used in case the aortic wall was insufficient. A small opening was then made on the right atrium and anastomosed to the aortic wall and pericardial patch to create a fistula between the perigraft pouch and right atrium (yellow circle)
Preoperative clinical characteristics
| Variable | CA group (n = 21) | NCA group(n = 108) | P |
|---|---|---|---|
| Male [n (%)] | 19 (90.5%) | 72 (66.7%) | |
| Age [years, mean ± SD] | 54.0 ± 7.8 | 54.3 ± 13.0 | 0.865 |
| Body surface area [m2, mean ± SD] | 1.89 ± 0.20 | 1.84 ± 0.25 | 0.332 |
| Cardiac surgery history [n (%)] | 0 (0.0%) | 5 (4.6%) | 0.591 |
| Hypertension [n (%)] | 15 (71.4%) | 75 (69.4%) | 0.856 |
| Diabetes mellitus [n (%)] | 1 (4.8%) | 3 (2.8%) | 0.513 |
| Coronary artery disease history [n (%)] | 0 (0%) | 2 (1.9%) | 1.000 |
| Smoking history [n (%)] | 13 (61.9%) | 44 (40.7%) | 0.074 |
| Intramural hematoma [n (%)] | 5 (23.8%) | 23 (21.3%) | 1.000 |
| Marfan syndrome [n (%)] | 0 (0.0%) | 10 (15.2%) | 0.217 |
| Any antiplatelet therapy [n (%)] | 21 (100%) | 1 (0.9%) | |
| Dual antiplatelet therapy [n (%)] | 18 (85.7%) | 0 (0.0%) | |
| Hypotension/shock [n (%)] | 13 (61.9%) | 38 (35.2%) | |
| Cardiac tamponade [n (%)] | 4 (19.0%) | 25 (23.1%) | 0.900 |
| Mesenteric malperfusion | 1 (4.8%) | 3 (2.8%) | 0.513 |
| Ischemic changes on ECG [n (%)] | 14 (66.7%) | 40 (37.0%) | |
| Troponin I [ng/ml, M (IRQ)] | 0.048 (0.251) | 0.022 (0.161) | 0.266 |
| Duration: onset to admission [hours, M (IRQ)] | 10.0 (12.0) | 11.0 (17.0) | 0.297 |
| Duration: admission to operation [hours, M (IRQ)] | 1.5 (3.0) | 1.5 (2.9) | 0.926 |
| Duration: onset to operation [hours, M (IRQ)] | 12.0 (17.0) | 14.0 (18.8) | 0.442 |
Bold values indicate statistically significant values, P < 0.05
Preoperative coagulation function, perioperative bleeding, and blood transfusion
| Variable | CA group (n = 21) | NCA group(n = 108) | P |
|---|---|---|---|
| INR [M (IRQ)] | 1.04 (0.14) | 1.04 (0.15) | 0.245 |
| aPTT [seconds, M (IRQ)] | 30.9 (7.6) | 29.0 (8) | 0.327 |
| Fibrinogen [g/L, M (IRQ)] | 2.00 (1.25) | 2.20 (1.57) | 0.318 |
| D-Dimer [mg/L, M (IRQ)] | 13.9 (26.8) | 9.34 (17.9) | 0.697 |
| Platelet count (109/L, mean ± SD) | 168.6 ± 62.3 | 157.5 ± 66.6 | 0.482 |
| R [reaction time, min, M (IRQ)] | 5.10 (3.37) | 4.70 (2.00) | 0.787 |
| K [potentiation phase, min, M (IRQ)] | 2.20 (1.10) | 1.80 (0.85) | 0.305 |
| α [rate of clot, degree, M (IRQ)] | 61.0 (21.7) | 62.4 (17.5) | 0.411 |
| MA [maximum amplitude, mm, M (IRQ)] | 60.0 (12.0) | 61.3 (11.5) | 0.679 |
| LY30 [fibrinolysis, %, M (IRQ)] | 0.00 (0.10) | 0.00 (0.05) | 0.822 |
| AA-induced platelet inhibition [%, M (IRQ)] | 92.0 (43.6) | 46.0 (44.2) | |
| ADP-induced platelet inhibition [%, M (IRQ)] | 91.4 (36.4) | 71.0 (55.4) | |
| Intraoperative bleeding [ml, M (IRQ)] | 1900 [1925] | 1500 [1100] | |
| Operative day | 1040 [1030] | 595 [685] | |
| 1st postoperative day | 460 [477.5] | 320 [440] & | 0.567 |
| 2nd postoperative day | 150 [280] | 130 [204] # | 0.642 |
| Re-exploration for bleeding [n (%)] | 3 (14.3%) | 14 (13.0%) | 1.000 |
| RBC [U, M (IRQ)] | 8 (14) | 6 (10) | 0.149 |
| Plasma [U, M (IRQ)] | 18 (25) | 12 (14) | 0.075 |
| Platelets [U, M (IRQ)] | 1 (2) | 0 (1) | |
Bold values indicate statistically significant values, P < 0.05
INR, international normalized ratio; aPTT, activated partial thromboplastin time; ADP, adenosine diphosphate; AA, arachidonic acid; RBC, red blood cell. &Missing data due to death of patients, n = 107. # Missing data due to death of patients, n = 106
Surgical intervention
| Variable | CA group (n = 21) | NCA group (n = 108) | P |
|---|---|---|---|
| Bentall procedure [n (%)] | 4 (19.0%) | 34 (31.5%) | 0.253 |
| Aortic valvuloplasty [n (%)] | 7 (33.3%) | 25 (23.1%) | 0.323 |
| Ascending aorta replacement [n (%)] | 17 (81%) | 70 (64.8%) | 0.205 |
| Hemi-arch replacement [n (%)] | 1 (4.8%) | 16 (14.8%) | 0.372 |
| Sun’s procedure [n (%)] | 18 (85.7%) | 73 (67.6%) | 0.096 |
| Ostium repair [n (%)] | 13 (61.9%) | 28 (25.9%) | |
| CABG [n (%)] | 1 (4.8%) | 4 (3.7%) | 1.000 |
| Overall intervention [n (%)] | 14 (66.7%) | 32 (29.6%) | |
| Operative time [minutes, M (IRQ)] | 319 (187.5) | 323.5 (112.3) | 0.674 |
| Time of CPB [minutes, M (IRQ)] | 168.0 (47.5) | 160.5 (47.6) | 0.794 |
| Time of ACC [minutes, M (IRQ)] | 86.0 (30.0) | 87.5 (24.0) | 0.728 |
| Time of DHCA [minutes, M (IRQ)] | 17.0 (6.0) | 18.0 (7.8) | 0.627 |
Bold values indicate statistically significant values, P < 0.05
CABG, coronary artery bypass grafting; CPB, cardiopulmonary bypass; ACC, aortic crossclamping; DHCA, deep hypothermic circulatory arrest; RBC: red blood cell; Sun’s procedure: total arch replacement + frozen elephant trunk procedure
Fig. 2Survival analysis showed no significant difference in overall survival between the two groups
Surgical mortality and postoperative complications
| Variable | CA group (n = 21) | NCA group (n = 108) | P |
|---|---|---|---|
| Surgical mortality [n (%)] | 1 (4.8%) | 10 (9.3%) | 0.804 |
| Low cardiac output syndrome [n (%)] | 0 (0.0%) | 6 (5.6%) | 0.588 |
| Cardiac tamponade [n (%)] | 2 (9.5%) | 13 (12.0%) | 1.000 |
| New-onset atrial fibrillation [n (%)] | 10 (47.6%) | 21 (19.4%) | |
| LV ejection fraction [%, mean ± SD] | 60.9 ± 6.9 | 61.3 ± 7.8 | 0.834 |
| LV fractional shortening [%, mean ± SD] | 32.7 ± 4.8 | 32.9 ± 5.5 | 0.860 |
| LV Wall motion abnormality [n (%)] | 2 (9.5%) | 13(12.1%) | 1.000 |
| Re-intubation [n (%)] | 2 (9.5%) | 13 (12.0%) | 1.000 |
| Tracheotomy [n (%)] | 2(9.5%) | 12(11.1%) | 1.000 |
| Acute renal failure [n (%)] | 2 (9.5%) | 6 (5.6%) | 0.845 |
| Coma [n (%)] | 1 (4.8%) | 10 (9.3%) | 0.804 |
| Hypoxic-ischemic encephalopathy [n (%)] | 1 (4.8%) | 6 (5.6%) | 1.000 |
| Cerebral infarction [n (%)] | 2 (9.5%) | 13(12.0%) | 1.000 |
| Cerebral hemorrhage [n (%)] | 1(4.8%) | 3(2.8%) | 0.513 |
| ICU stay [hours, M (IRQ)] | 92.0 (129.8) | 63.5 (68,7) | 0.193 |
| ICU readmission* [n (%)] | 6 (30.0%) | 8 (7.7%) | |
| Hospital stay [days, M (IRQ)] | 18.0 (16.5) | 13.0 (10.0) | 0.056 |
| 30-day readmission* [n (%)] | 2 (10%) | 17 (16.3%) | 0.702 |
Bold values indicate statistically significant values, P < 0.05
ICU, intensive care unit. *As patients died in ICU were excluded, 20 in the CA group and 104 patients in NCA group were included